Time to make some sense of reimbursement in Europe
This article was originally published in Clinica
Executive Summary
Medical device reimbursement and funding policies in Europe are complex and perplexing. They represent a costly, moving target to manufacturers. The following excerpt from a paper given recently by Clinica's European regulatory affairs editor, Amanda Maxwell, at a European conference on Reimbursement*, looks at the problems and possible ways forward.